![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1521701
Äݶó°Õ µå·¹½Ì : ½ÃÀå Á¡À¯À² ºÐ¼®, »ê¾÷ µ¿Çâ ¹× Åë°è, ¼ºÀå ¿¹Ãø(2024-2029³â)Collagen Dressings - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) |
Äݶó°Õ µå·¹½Ì ½ÃÀå ±Ô¸ð´Â 2024³â 12¾ï ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2029³â¿¡´Â 14¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£(2024-2029) µ¿¾È ¿¬Æò±Õ 5.15% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Äݶó°Õ µå·¹½Ì¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁÖµµÇÏ´Â °ÍÀº ±Þ¼º ¹× ¸¸¼º »óóÀÇ Áõ°¡¿Í Àü ¼¼°è ¿Ü°ú ¼ö¼úÀÇ Áõ°¡ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 7¿ù National Center for Biotechnology Information¿¡ °ÔÀçµÈ ±â»ç¿¡ µû¸£¸é Àü ¼¼°èÀûÀ¸·Î ¿¬°£ ¾à 1,860¸¸ ¸íÀÌ ´ç´¢º´¼º Á·ºÎ±Ë¾çÀ» ¾Î°í ÀÖÀ¸¸ç, ¹Ì±¹¿¡¼´Â 1,600¸¸ ¸íÀÌ ´ç´¢º´¼º Á·ºÎ±Ë¾çÀ» ¾Î°í ÀÖ´Ù°í ÇÕ´Ï´Ù(2023³â 5¿ù ¾÷µ¥ÀÌÆ®). Interburns OrganizationÀÇ ±â»ç¿¡ µû¸£¸é, ¸Å³â ¾à 1,100¸¸ ¸íÀÌ È»óÀ» ÀԴ´ٰí ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ »óóÀÇ ³ôÀº À¯º´·üÀº È¿°úÀûÀÎ Ä¡·á ¿É¼ÇÀÇ Çʿ伺À» ÃËÁøÇÏ¿© ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
Äݶó°Õ µå·¹½ÌÀº È»ó, ±Ë¾ç, ´ç´¢¼º ±Ë¾ç, Á¤¸Æ¼º ±Ë¾ç, ¿åâ°ú °°Àº ±Ë¾ç °ü¸®¿¡ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. Àü ¼¼°è ´ç´¢º´ ȯÀÚ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó ´ç´¢º´¼º Á·ºÎ±Ë¾ç ȯÀÚ´Â Àü ¼¼°èÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ Áúº´ÅëÁ¦¿¹¹æ¼¾ÅÍ(Centers for Disease Control and Prevention)ÀÇ 2022³â 6¿ù ¾÷µ¥ÀÌÆ®µÈ º¸°í¼¿¡ µû¸£¸é, ´ç´¢º´ ȯÀÚÀÇ 12.0%°¡ Æò»ý µ¿¾È ´ç´¢º´¼º Á·ºÎ±Ë¾çÀ» ¾Î°í ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ¸¹Àº ÀÇ·á Àü¹®°¡µéÀÌ ´ç´¢º´¼º Á·ºÎ±Ë¾çÀ» Ä¡·áÇϱâ À§ÇØ Äݶó°Õ µå·¹½ÌÀ» »ç¿ëÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ÇâÈÄ ¸î ³â µ¿¾È Äݶó°Õ µå·¹½Ì ½ÃÀåÀÇ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¶ÇÇÑ, ³ëÀÎ Àα¸ÀÇ Áõ°¡·Î ÀÎÇØ Á¤¸Æ¼º ÇÏÁö ±Ë¾ç ȯÀÚ ¼ö°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â Äݶó°Õ µå·¹½Ì ½ÃÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 11¿ù Journal of Vascular Surgery¿¡ °ÔÀçµÈ ¿¬±¸¿¡ µû¸£¸é, Á¤¸Æ¼º ÇÏÁö ±Ë¾çÀº Àüü Àα¸ÀÇ 1.0%-2.0%°¡ ¾Î°í ÀÖÀ¸¸ç, 65¼¼ À̻󿡼´Â À¯º´·üÀÌ 4.0% Áõ°¡Çß´Ù°í ÇÕ´Ï´Ù. ¶ÇÇÑ, ½ºÄÚÆ²·£µå National Health Information ServiceÀÇ 2023³â 2¿ù ¾÷µ¥ÀÌÆ®¿¡ µû¸£¸é, Á¤¸Æ¼º ÇÏÁö ±Ë¾çÀº ¿µ±¹¿¡¼ 500¸í Áß 1¸í²Ã·Î ¹ßº´ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ ºñÀ²Àº ¿¬·É¿¡ µû¶ó Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. 2022³â¿¡´Â 80¼¼ ÀÌ»ó 50¸í Áß 1¸íÀÌ Á¤¸Æ¼º ÇÏÁö ±Ë¾çÀ» ¾Î°Ô µÉ °ÍÀ̶ó°í ¹àÇû½À´Ï´Ù. µû¶ó¼ ÀÌ·¯ÇÑ ¿äÀεéÀº Äݶó°Õ µå·¹½Ì¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃÄÑ ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.
Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºêÀÇ Áõ°¡¿Í ¸¸¼º »óó¿¡ ´ëÇÑ ¾ÈÀüÇÑ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÇâÈÄ 5³â µ¿¾È ½ÃÀå¿¡ ¸¹Àº ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª Æû µå·¹½Ì ¹× ÇÏÀ̵å·ÎÄÝ·ÎÀÌµå µå·¹½Ì°ú °°Àº Äݶó°Õ µå·¹½ÌÀÇ ´ëü Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ³ôÀº Á¢±Ù¼º°ú ±âÁ¸ »óó µå·¹½Ì¿¡ ºñÇØ ³ôÀº ºñ¿ëÀº ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ¾ïÁ¦ÇÒ ¼ö ÀÖ½À´Ï´Ù.
Äݶó°Õ µå·¹½Ì ½ÃÀåÀº ÁÖ¿ä ±â¾÷ÀÇ °·ÂÇÑ Á¦Ç° Æ÷Æ®Æú¸®¿À¿Í źźÇÑ ÆÇ¸Å¸ÁÀ¸·Î ÀÎÇØ ¼¼ºÐȵǾî ÀÖ½À´Ï´Ù. ÁÖ¿ä ±â¾÷µéÀº ¿¬±¸°³¹ß Ȱµ¿¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖÀ¸¸ç, À̸¦ ÅëÇØ ½ÅÁ¦Ç°À» Ãâ½ÃÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, M&A¸¦ ÅëÇÑ ÆÄÆ®³Ê½Ê Çü¼º, Á¤ºÎ ½ÂÀÎ È®º¸, Çù·Â °ü°è ÁõÁø µî ´Ù¾çÇÑ ¼ºÀå Àü·«ÀÇ ½ÇÇà¿¡ ÁýÁßÇÏ¿© ½ÃÀå¿¡¼ÀÇ ÀÔÁö¸¦ °ÈÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ½ÃÀå ÁøÀÔ ±â¾÷À¸·Î´Â 3M, Smith Nephew, DermaRite Industries, LLC, Coloplast Corp. µîÀÔ´Ï´Ù.
The Collagen Dressings Market size is estimated at USD 1.20 billion in 2024, and is expected to reach USD 1.47 billion by 2029, growing at a CAGR of 5.15% during the forecast period (2024-2029).
The rising cases of acute and chronic wounds among individuals and a growing number of surgical procedures worldwide mainly drive the demand for collagen dressings. For instance, according to an article published in the National Center for Biotechnology Information in July 2023, around 18.6 million people worldwide are affected by diabetic foot ulcers yearly, including 1.6 million people in the United States. As per the updated article in May 2023 by Interburns Organization, around 11.0 million people are affected with burns each year. Such a high prevalence of wounds drives the need for effective treatment options, thereby propelling market growth.
Collagen dressings are crucial in managing burns, sores, and ulcers such as diabetic, venous, and pressure ulcers. The cases of diabetic foot ulcer patients are increasing globally owing to the rise in the number of diabetic patients worldwide. For instance, as per the Centers for Disease Control and Prevention report, updated in June 2022, 12.0% of people who have diabetes develop diabetic foot ulcers over their lifetime. Many healthcare professionals use collagen dressing to heal diabetic foot ulcers, which is further anticipated to drive the demand for collagen dressings market in the coming years.
Furthermore, the rise in the elderly population is expected to increase the number of patients suffering from venous leg ulcers, which is anticipated to propel the market for collagen dressings. For instance, according to a research study published in the Journal of Vascular Surgery in November 2022, venous leg ulcers affect 1.0% to 2.0% of the population, with the prevalence increasing by 4.0% for those aged more than 65 years. Additionally, as per the update in February 2023 by Scotland's National Health Information Service, venous leg ulcers are anticipated to affect nearly one in 500 people in the United Kingdom, and the rate is projected to increase with age. The same study stated that one in 50 people over 80 years old were affected with venous leg ulcers in 2022. Thus, these factors have increased the demand for collagen dressings, influencing market growth.
A rise in government initiatives and increased demand for safe treatment options for chronic wounds can create numerous growth opportunities for the market in the next five years. However, the high accessibility to alternative treatment options for collagen dressings, such as foam and hydrocolloid dressings, and the high cost compared to conventional wound dressings may restrain market growth during the forecast period.
The collagen dressings market is fragmented due to a strong product portfolio and robust distribution network of major players. Prominent players invest significantly in research and development activities, leading to new product launches. Furthermore, focusing on implementing various growth strategies such as forming partnerships through mergers and acquisitions, securing government approvals, and fostering collaborations are expanding their presence in the market. Some key market players are 3M, Smith+Nephew, DermaRite Industries, LLC, Coloplast Corp., McKesson Medical-Surgical Inc., Convatec Group PLC, and Organogenesis Inc.